1-(tert-Butyldimethylsilyl)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole → HCID 53378790, compound
Reaction equation
Cl[C:2]1[N:3]=[C:4]([N:20]2[CH2:25][CH2:24][O:23][CH2:22][CH2:21]2)[C:5]2[N:11]=[C:10]([CH2:12][N:13]([CH3:19])[CH2:14][C:15]([CH3:18])([OH:17])[CH3:16])[CH:9]=[CH:8][C:6]=2[N:7]=1.[Si]([N:33]1[C:41]2[C:36](=[C:37](B3OC(C)(C)C(C)(C)O3)[C:38]([F:42])=[CH:39][CH:40]=2)[CH:35]=[CH:34]1)(C(C)(C)C)(C)C>>[F:42][C:38]1[C:37]([C:2]2[N:3]=[C:4]([N:20]3[CH2:25][CH2:24][O:23][CH2:22][CH2:21]3)[C:5]3[N:11]=[C:10]([CH2:12][N:13]([CH3:19])[CH2:14][C:15]([CH3:18])([OH:17])[CH3:16])[CH:9]=[CH:8][C:6]=3[N:7]=2)=[C:36]2[C:41](=[CH:40][CH:39]=1)[NH:33][CH:34]=[CH:35]2Participants
3
Procedure
1-(((2-chloro-4-morpholinopyrido[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)-2-methylpropan-2-ol from Example 143 (0.12 g) was reacted with 1-(tert-butyldimethylsilyl)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole via General Procedure A to produce 35.6 mg of 140 following reverse phase HPLC purification. MS (Q1) 465.2 (M)+
Workup
- customto produce
- custom35.6 mg of 140 following reverse phase HPLC purification
Sources & evidence
- ORD record
- ord-d66599e35d8340e38c3566d127e1c5f0
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08440651B2
Reaction notes
Loading…